Filling the gap: investigating the interpretability of the Recap of atopic eczema questionnaire
According to the Global Burden of Disease Study, atopic dermatitis (AD) ranks number 15 among all nonfatal diseases and has the highest disease burden among skin diseases.1 AD is a chronically relapsing inflammatory skin condition characterized by dry, itchy and inflamed skin, and is associated with...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2023
|
| In: |
British journal of dermatology
Year: 2023, Volume: 189, Issue: 5, Pages: 506-507 |
| ISSN: | 1365-2133 |
| DOI: | 10.1093/bjd/ljad287 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/bjd/ljad287
|
| Author Notes: | Robert F. Ofenloch |
| Summary: | According to the Global Burden of Disease Study, atopic dermatitis (AD) ranks number 15 among all nonfatal diseases and has the highest disease burden among skin diseases.1 AD is a chronically relapsing inflammatory skin condition characterized by dry, itchy and inflamed skin, and is associated with emotional and behavioural problems.2 Therefore, it is important to assess disease control over time in patients with AD, both in clinical trials addressing new treatments for AD and in clinical practice. It can support clinicians in identifying environmental or emotional factors triggering the disease. |
|---|---|
| Item Description: | Veröffentlicht: 09. August 2023 Gesehen am 16.10.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1365-2133 |
| DOI: | 10.1093/bjd/ljad287 |